Safety and tolerability of Neoral in transplant recipients

被引：0
|
作者：
Feutren, G [1 ]
Wong, R [1 ]
Jin, J [1 ]
Niese, D [1 ]
Mellein, B [1 ]
机构：
[1] SANDOZ PHARMA LTD,CLIN RES,CH-4002 BASEL,SWITZERLAND
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2177 / 2182
页数：6
相关论文
共 50 条
  • [1] Safety, tolerability, and pharmacokinetics of sandimmun neoral: Conversion study in stable renal transplant recipients
    Tsang, WK
    Ho, YW
    Tong, ML
    Chan, WH
    Chan, A
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (03) : 1330 - 1332
  • [2] An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoral
    Pasha, TM
    Wiesner, RH
    Dahlke, LM
    Porayko, MK
    Krom, RAF
    LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (05): : 410 - 415
  • [3] Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients
    Grant, D
    Rochon, J
    Levy, G
    Cattral, M
    Cheung, S
    Grieg, P
    Altraif, I
    Rezieg, M
    Wong, PY
    Adams, P
    Asfar, S
    Freeman, D
    Ghent, C
    Wall, W
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2232 - 2233
  • [4] Safety, Effectiveness, and Tolerability of Patiromer in Kidney Transplant Recipients
    Lim, Mary Ann
    Sawinski, Deirdre
    Trofe-Clark, Jennifer
    TRANSPLANTATION, 2019, 103 (09) : E281 - E282
  • [5] UK multicentre study to assess the safety and tolerability of Neoral in stable renal transplant patients
    Moore, RH
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2202 - 2203
  • [6] USE OF NEORAL IN HEART-TRANSPLANT RECIPIENTS
    MIKHAIL, G
    EADON, H
    LEAVER, N
    YACOUB, M
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2985 - 2987
  • [7] Pharmacokinetics, efficacy, and safety of iminoral compared with neoral in healthy volunteers and renal transplant recipients
    Sayyah, M.
    Argani, H.
    Pourmand, Gh. R.
    Amini, H.
    Ahmadiani, A.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (04) : 1214 - 1218
  • [8] CYCLOSPORINE NEORAL IN LIVER-TRANSPLANT RECIPIENTS
    LEVY, G
    ALTRAIF, I
    REZIEG, M
    ASFAR, S
    ROCHON, J
    FREEMAN, D
    WONG, PY
    BANKS, L
    ROACH, C
    ENGEL, K
    GRANT, D
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3184 - 3187
  • [9] Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients
    Gaston, R
    Alloway, RR
    Gaber, AO
    Rossi, SJ
    Schroeder, TJ
    Irish, WD
    Canafax, DM
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 326 - 327
  • [10] Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients
    Barone, G
    Bunke, CM
    Choc, MG
    Hricik, DE
    Jin, JHJ
    Klein, JB
    Marsh, CL
    Min, DI
    Pescovitz, MD
    Pollak, R
    Pruett, TL
    Stinson, JB
    Thompson, JS
    Vasquez, E
    Waid, T
    Wombolt, DG
    Wong, RL
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2183 - 2186
12345